Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-25-034816

Director bought 168 shares at an average $4.80 ($807)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jones James Director 2025-06-02 Purchase 10b5-1 +8 $5.20 $42 43,176 D
Jones James Director 2025-06-03 Purchase 10b5-1 +8 $5.61 $45 43,184 D
Jones James Director 2025-06-04 Purchase 10b5-1 +8 $5.75 $46 43,192 D
Jones James Director 2025-06-05 Purchase 10b5-1 +8 $5.46 $44 43,200 D
Jones James Director 2025-06-06 Purchase 10b5-1 +8 $5.57 $45 43,208 D
Jones James Director 2025-06-09 Purchase 10b5-1 +8 $5.94 $48 43,216 D
Jones James Director 2025-06-10 Purchase 10b5-1 +8 $6.00 $48 43,224 D
Jones James Director 2025-06-11 Purchase 10b5-1 +8 $5.57 $45 43,232 D
Jones James Director 2025-06-12 Purchase 10b5-1 +8 $5.67 $45 43,240 D
Jones James Director 2025-06-13 Purchase 10b5-1 +8 $5.81 $46 43,248 D
Jones James Director 2025-06-16 Purchase 10b5-1 +8 $5.32 $43 43,256 D
Jones James Director 2025-06-17 Purchase 10b5-1 +8 $5.61 $45 43,264 D
Jones James Director 2025-06-18 Purchase 10b5-1 +8 $5.52 $44 43,272 D
Jones James Director 2025-06-20 Purchase 10b5-1 +8 $5.29 $42 43,280 D
Jones James Director 2025-06-23 Purchase 10b5-1 +8 $4.61 $37 43,288 D
Jones James Director 2025-06-24 Purchase 10b5-1 +8 $3.91 $31 43,296 D
Jones James Director 2025-06-25 Purchase 10b5-1 +8 $3.27 $26 43,304 D
Jones James Director 2025-06-26 Purchase 10b5-1 +8 $2.71 $22 43,312 D
Jones James Director 2025-06-27 Purchase 10b5-1 +8 $2.60 $21 43,320 D
Jones James Director 2025-06-30 Purchase 10b5-1 +16 $2.74 $44 43,336 D
Open-market purchases · 168 sh · avg $4.80 · $807
Loading xslF345X05/wk-form4_1752270525.xml…